These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay. Hicks MJ; Grogan TM; Fielder K; Spier CM Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864 [TBL] [Abstract][Full Text] [Related]
10. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628 [TBL] [Abstract][Full Text] [Related]
11. "T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow. Aboul-Nasr R; O'Brien S; Freireich EJ; Ginsberg CF; Kantarjian HM; Koller CA; Keating MJ; Albitar M Leuk Lymphoma; 2001; 42(5):1023-31. PubMed ID: 11697619 [TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytosis with neutropenia: evidence for a novel, abnormal T-cell population associated with antibody-mediated neutrophil destruction. Starkebaum G; Martin PJ; Singer JW; Lum LG; Price TH; Kadin ME; Raskind WH; Fialkow PJ Clin Immunol Immunopathol; 1983 Apr; 27(1):110-23. PubMed ID: 6603312 [TBL] [Abstract][Full Text] [Related]
13. A fatal lymphoproliferative disorder with a suppressor T-cell phenotype. Neoplastic, reactive, or both? Barr RD; McDermott M; Giron D Am J Pediatr Hematol Oncol; 1985; 7(2):148-55. PubMed ID: 2947509 [TBL] [Abstract][Full Text] [Related]
14. Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. Lipton JM; Nadler LM; Canellos GP; Kudisch M; Reiss CS; Nathan DG J Clin Invest; 1983 Aug; 72(2):694-706. PubMed ID: 6223945 [TBL] [Abstract][Full Text] [Related]
15. Lymphocytic lymphoma simulating hairy cell leukemia: a consideration of reliable and unreliable diagnostic features. Palutke M; Tabaczka P; Mirchandani I; Goldfarb S Cancer; 1981 Nov; 48(9):2047-55. PubMed ID: 6975157 [TBL] [Abstract][Full Text] [Related]
16. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases]. Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691 [No Abstract] [Full Text] [Related]
17. T lymphocytes involved in inhibition of granulopoiesis in two neutropenic patients are of the cytotoxic/suppressor (T3+T8+) subset. Bagby GC J Clin Invest; 1981 Dec; 68(6):1597-600. PubMed ID: 6459342 [TBL] [Abstract][Full Text] [Related]
18. Splenic B-cell lymphoma with villous lymphocytes (SLVL). A lymphocytic lymphoma simulating hairy cell leukemia. A study of 8 cases. Valensi F; Durand V; Bastenaire B; Flandrin G Nouv Rev Fr Hematol (1978); 1990; 32(6):409-14. PubMed ID: 2101874 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of CFU-GM by prostaglandins in a case of chronic T-cell lymphocytosis and neutropenia. Smith JG; Smith MA; James I; Blundell E; Maddison PJ Br J Haematol; 1989 Oct; 73(2):148-51. PubMed ID: 2818937 [TBL] [Abstract][Full Text] [Related]